These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16921881)

  • 1. Detection of antibodies to West Nile virus in equine sera using microsphere immunoassay.
    Balasuriya UB; Shi PY; Wong SJ; Demarest VL; Gardner IA; Hullinger PJ; Ferraro GL; Boone JD; De Cino CL; Glaser AL; Renshaw RW; Ledizet M; Koski RA; MacLachlan NJ
    J Vet Diagn Invest; 2006 Jul; 18(4):392-5. PubMed ID: 16921881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of assays for the detection of West Nile virus antibodies in equine serum after natural infection or vaccination.
    Joó K; Bakonyi T; Szenci O; Sárdi S; Ferenczi E; Barna M; Malik P; Hubalek Z; Fehér O; Kutasi O
    Vet Immunol Immunopathol; 2017 Jan; 183():1-6. PubMed ID: 28063471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum antibodies to West Nile virus in naturally exposed and vaccinated horses.
    Magnarelli LA; Bushmich SL; Anderson JF; Ledizet M; Koski RA
    J Med Microbiol; 2008 Sep; 57(Pt 9):1087-1093. PubMed ID: 18719177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic responses to West Nile virus in vaccinated and clinically affected horses.
    Davidson AH; Traub-Dargatz JL; Rodeheaver RM; Ostlund EN; Pedersen DD; Moorhead RG; Stricklin JB; Dewell RD; Roach SD; Long RE; Albers SJ; Callan RJ; Salman MD
    J Am Vet Med Assoc; 2005 Jan; 226(2):240-5. PubMed ID: 15706975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-reactivity of Japanese encephalitis virus-vaccinated horse sera in serodiagnosis of West Nile virus.
    Hirota J; Nishi H; Matsuda H; Tsunemitsu H; Shimiz S
    J Vet Med Sci; 2010 Mar; 72(3):369-72. PubMed ID: 19996564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.
    El Garch H; Minke JM; Rehder J; Richard S; Edlund Toulemonde C; Dinic S; Andreoni C; Audonnet JC; Nordgren R; Juillard V
    Vet Immunol Immunopathol; 2008 Jun; 123(3-4):230-9. PubMed ID: 18372050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anamnestic serologic response to vaccination with a canarypox virus-vectored recombinant West Nile virus (WNV) vaccine in horses previously vaccinated with an inactivated WNV vaccine.
    Grosenbaugh DA; Backus CS; Karaca K; Minke JM; Nordgren RM
    Vet Ther; 2004; 5(4):251-7. PubMed ID: 15719324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and effects of West Nile virus infection in vaccinated and unvaccinated horses in California.
    Gardner IA; Wong SJ; Ferraro GL; Balasuriya UB; Hullinger PJ; Wilson WD; Shi PY; MacLachlan NJ
    Vet Res; 2007; 38(1):109-16. PubMed ID: 17274156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope-blocking enzyme-linked immunosorbent assay to differentiate west nile virus from Japanese encephalitis virus infections in equine sera.
    Kitai Y; Shoda M; Kondo T; Konishi E
    Clin Vaccine Immunol; 2007 Aug; 14(8):1024-31. PubMed ID: 17596430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. West Nile virus-specific immunoglobulin isotype responses in vaccinated and infected horses.
    Khatibzadeh SM; Gold CB; Keggan AE; Perkins GA; Glaser AL; Dubovi EJ; Wagner B
    Am J Vet Res; 2015 Jan; 76(1):92-100. PubMed ID: 25535666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific antibody responses to West Nile virus infections in horses preimmunized with inactivated Japanese encephalitis vaccine: evaluation of blocking enzyme-linked immunosorbent assay and complement-dependent cytotoxicity assay.
    Kitai Y; Shirafuji H; Kanehira K; Kamio T; Kondo T; Konishi E
    Vector Borne Zoonotic Dis; 2011 Aug; 11(8):1093-8. PubMed ID: 21254919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV).
    Rosas CT; Tischer BK; Perkins GA; Wagner B; Goodman LB; Osterrieder N
    Virus Res; 2007 Apr; 125(1):69-78. PubMed ID: 17241683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equine vaccine for West Nile virus.
    Ng T; Hathaway D; Jennings N; Champ D; Chiang YW; Chu HJ
    Dev Biol (Basel); 2003; 114():221-7. PubMed ID: 14677692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Cross-Protection of a Lineage 1 West Nile Virus Inactivated Vaccine against Natural Infections from a Virulent Lineage 2 Strain in Horses, under Field Conditions.
    Chaintoutis SC; Diakakis N; Papanastassopoulou M; Banos G; Dovas CI
    Clin Vaccine Immunol; 2015 Sep; 22(9):1040-9. PubMed ID: 26178384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-structural protein 1 (NS1) antibody-based assays to differentiate West Nile (WN) virus from Japanese encephalitis virus infections in horses: effects of WN virus NS1 antibodies induced by inactivated WN vaccine.
    Kitai Y; Kondo T; Konishi E
    J Virol Methods; 2011 Jan; 171(1):123-8. PubMed ID: 20974180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum neutralising antibody titres against a lineage 2 neuroinvasive West Nile Virus strain in response to vaccination with an inactivated lineage 1 vaccine in a European endemic area.
    Fehér O; Bakonyi T; Barna M; Nagy A; Takács M; Szenci O; Joó K; Sárdi S; Korbacska-Kutasi O
    Vet Immunol Immunopathol; 2020 Sep; 227():110087. PubMed ID: 32629300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A recombinant fusion protein consisting of West Nile virus envelope domain III fused in-frame with equine CD40 ligand induces antiviral immune responses in horses.
    Liu SA; Haque M; Stanfield B; Andrews FM; Roy AA; Kousoulas KG
    Vet Microbiol; 2017 Jan; 198():51-58. PubMed ID: 28062007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A glycosylated peptide in the West Nile virus envelope protein is immunogenic during equine infection.
    Hobson-Peters J; Toye P; Sánchez MD; Bossart KN; Wang LF; Clark DC; Cheah WY; Hall RA
    J Gen Virol; 2008 Dec; 89(Pt 12):3063-3072. PubMed ID: 19008394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralising antibodies for West Nile virus in horses from Brazilian Pantanal.
    Pauvolid-Corrêa A; Morales MA; Levis S; Figueiredo LT; Couto-Lima D; Campos Z; Nogueira MF; da Silva EE; Nogueira RM; Schatzmayr HG
    Mem Inst Oswaldo Cruz; 2011 Jun; 106(4):467-74. PubMed ID: 21739036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement-dependent cytotoxicity assay for differentiating West Nile virus from Japanese encephalitis virus infections in horses.
    Kitai Y; Kondo T; Konishi E
    Clin Vaccine Immunol; 2010 May; 17(5):875-8. PubMed ID: 20237201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.